SCHEMBL331199

SCHEMBL331199

CCCCCCCCCCCCC(C)C(C)(C)N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.48
SPHK1 Q9NYA1 2/20 0.45
LMNA P02545 2/20 0.39
TP53 P04637 2/20 0.39
DNM1 Q05193 2/20 0.39
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
CYP2D6 P10635 2/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
PLA2G1B P04054 1/20 0.38
PLA2G2A P14555 1/20 0.38
GMNN O75496 1/20 0.38
POLB P06746 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8385121 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL8385082 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL924201 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL8386214 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL332857 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL8383457 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL125359 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL17257510 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL37786 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1
SCHEMBL2266510 1.00 OPRM1 (0.48) OPRM1SPHK1LMNATP53DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3801032-B1 HERBICIDAL COMPOSITIONS MONSANTO TECHNOLOGY LLC (US) 2025-12-10 EP claimed
US-12342817-B2 Herbicidal compositions MONSANTO TECHNOLOGY LLC (US) 2025-07-01 US claimed
US-20250113829-A1 HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS nanoSUR LLC 2025-04-10 US claimed
US-20210244024-A1 Herbicidal Compositions MONSANTO TECHNOLOGY LLC 2021-08-12 US claimed
EP-3801032-A1 HERBICIDAL COMPOSITIONS Monsanto Technology LLC (US) 2021-04-14 EP claimed
US-20150313846-A1 PROLONGED-RELEASE MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM FLAMEL IRELAND LIMITED (IE) 2015-11-05 US claimed
US-20110269029-A1 DIRECT ALCOHOL ANION FUEL CELL WITH BIOCATHODE AKERMIN, INC. (US) 2011-11-03 US claimed
EP-2370540-A1 PHASE-TRANSITIONAL MATERIAL, METHOD OF MANUFACTURING THEREOF AND METHOD OF MANUFACTURING MODULE WITH PHASE-TRANSITIONAL MATERIAL Quantum Energy Research Centre (KR) 2011-10-05 EP claimed
US-20110232067-A1 PHASE-TRANSITIONAL MATERIAL, METHOD OF MANUFACTURING THEREOF AND METHOD OF MANUFACTURING MODULE WITH PHASE-TRANSITIONAL MATERIAL QUANTUM ENERGY RESEARCH CENTRE (KR) 2011-09-29 US claimed
EP-2362809-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE Akermin, Inc. (US) 2011-09-07 EP claimed
EP-0707489-A4 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF SCOTGEN BIOPHARMACEUTICALS INC (US) 1998-07-29 EP claimed
EP-0707489-A1 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF Scotgen Biopharmaceuticals, Inc. (US) 1996-04-24 EP claimed
EP-0444481-B1 Process for preparing amines HOECHST AG (DE) 1995-05-03 EP claimed
WO-1994025053-A1 ATHEROSCLEROTIC PLAQUE SPECIFIC ANTIGENS, ANTIBODIES THERETO, AND USES THEREOF SCOTGEN BIOPHARMACEUTICALS, INC. (US) 1994-11-10 WO claimed
US-5149876-A Bealting an olefin with carbon monoxide hydrogen and primary and/or secondary amines in presence of rhodium-arylphospine salt complex HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-22 US claimed
EP-0302375-B1 PROCESS FOR THE PREPARATION OF ALDEHYDES HOECHST AKTIENGESELLSCHAFT (DE) 1992-04-15 EP claimed
EP-0141628-B1 ANTIMICROBIAL LATEX COMPOSITION SHAPED ARTICLE PRODUCED THEREFROM, AND METHOD OF MANUFACTURING A SHAPED ARTICLE UNITIKA LTD. (JP) 1989-10-18 EP claimed
US-4675347-A Antimicrobial latex composition UNITIKA LTD. (JP) 1987-06-23 US claimed
EP-0141628-A1 Antimicrobial latex composition shaped article produced therefrom, and method of manufacturing a shaped article UNITIKA LTD. (JP) 1985-05-15 EP claimed
US-4225498-A Preparation of N-substituted oligo-imides RHONE-POULENC INDUSTRIES (FR) 1980-09-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250113829-A1 HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS NSUN2, NSUN3, RNGTT OPRM1 1944/4885SPHK1 2690/4885LMNA 606/4885
US-20210244024-A1 Herbicidal Compositions DDT, HDHD5, ACHE OPRM1 3934/4885SPHK1 2458/4885LMNA 3929/4885
US-12342817-B2 Herbicidal compositions DDT, HDHD5, ACHE OPRM1 3934/4885SPHK1 2458/4885LMNA 3929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.